Six, not eight cycles of bi-weekly CHOP with rituximab (RCHOP-14) is the preferred treatment for elderly patients with diffuse large B-cell lymphoma (DLBCL): Results of the RICOVER-60 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL).

被引：0

作者：

Pfreundschuh, M ^{[1
]}

Kloess, M ^{[1
]}

Schmits, R ^{[1
]}

Zeynalova, S ^{[1
]}

Lengfelder, E ^{[1
]}

Franke, A ^{[1
]}

Steinhauer, H ^{[1
]}

Reiser, M ^{[1
]}

Clemens, M ^{[1
]}

Nickenig, C ^{[1
]}

de Wit, M ^{[1
]}

Hoffmann, M ^{[1
]}

Mertelsmann, R ^{[1
]}

Metzner, B ^{[1
]}

Ho, A ^{[1
]}

Truemper, L ^{[1
]}

Eimermacher, H ^{[1
]}

Mergenthaler, H ^{[1
]}

Liersch, R ^{[1
]}

Duehrsen, U ^{[1
]}

Balleisen, L ^{[1
]}

Hartmann, F ^{[1
]}

Poeschel, V ^{[1
]}

Schmitz, N ^{[1
]}

Loeffler, M ^{[1
]}

机构：

[1] Univ Saarland, Sch Med, Med Klin 1,DSHNHl, German High Grade Non Hodgkin Lymphoma Study Grp, D-6650 Homburg, Saarland, Germany

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9A / 9A

页数：1

共 50 条

[41] Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Hohloch, Karin
Ziepert, Marita
Truemper, Lorenz
Buske, Christian
Held, Gerhard
Poeschel, Viola
Chapuy, Bjoern
Altmann, Bettina
EJHAEM, 2020, 1 (01): : 181 - 187
[42] Validation of German High-Grade Non-Hodgkin's Lymphoma (DSHNHL) Prognostic Model and the Impact of Treatment on Secondary Central Nervous System (CNS) Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) in a Developing Country: Report from the Nationwide Multi-Institutional Registry of Thai Lymphoma Study Group (TLSG)
Wudhikarn, Kitsada
Bunworasate, Udomsak
Lekhakula, Arnuparp
Julamanee, Jakrawadee
Sirijerachai, Chittima
Chansung, Kanchana
Norasetthada, Lalita
Nawarawong, Weerasak
Khuhapinant, Archrob
Ekwattanakit, Supachai
Numbenjapon, Tontanai
Prayongratana, Kannadit
Chuncharunee, Suporn
Niparuck, Pimjai
Suwanban, Tawatchai
Kanitsap, Nonglak
Wongkhantee, Somchai
Pornvipavee, Rachanid
Wong, Peerapon
Makruasi, Nisa
Praditsuktavorn, Pannee
Intragumtornchai, Tanin
BLOOD, 2015, 126 (23)
[43] A phase III trial comparing R-CHOP 14 and R-CHOP 21 for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin's lymphoma
Cunningham, D.
Smith, P.
Mouncey, P.
Qian, W.
Pocock, C.
Ardeshna, K. M.
Radford, J.
Davies, J.
McMillan, A.
Linch, D.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[44] The myocan phase II study of cyclophosphamide, oncovin, Myocet™ and prednisone plus rituximab (R-COMP) in elderly patients with diffuse large B-cell (DLBCL) non-Hodgkin lymphoma
Federico, M
Caballero, M
Dyer, M
Luminari, S
Thiel, E
ANNALS OF ONCOLOGY, 2005, 16 : 104 - 104
[45] Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA
Poeschel, Viola
Held, Gerhard
Ziepert, Marita
Altmann, Bettina
Witzens-Harig, Mathias
Holte, Harald
Thurner, Lorenz
Viardot, Andreas
Borchmann, Peter
Kanz, Lothar
Keller, Ulrich
Schmidt, Christian
Mahlberg, Rolf
Metzner, Bernd
Marks, Reinhard
Hoeffkes, Heinz-Gert
Christofyllakis, Konstantinos
Amam, Josif
Berdel, Christian
Stilgenbauer, Stephan
Schmitz, Norbert
Truemper, Lorenz
Murawski, Niels
Loeffler, Markus
Pfreundschuh, Michael
BLOOD, 2018, 132
[46] The MYOCAN study.: A phase II study of cyclophosphamide, oncovin, Myocet™, and prednisone plus rituximab (R-COMP) in the treatment of elderly patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL).
Federico, M
Dyer, MJS
Caballero, MD
Reilly, C
Thiel, E
BLOOD, 2004, 104 (11) : 230B - 231B
[47] Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).
Pfreundschuh, Michael
Murawski, Niels
Zeynalova, Samira
Poeschel, Viola
Reiser, Marcel
Ho, Anthony D.
Nickenig, Christina
Wessendorf, Swen
Metzner, Bernd
Grass, Sandra
Schubert, Joerg
Loeffler, Markus
Schmitz, Norbert
BLOOD, 2009, 114 (22) : 1431 - 1431
[48] Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial
Huettmann, Andreas
Rekowski, Jan
Mueller, Stefan P.
Hertenstein, Bernd
Franzius, Christiane
Mesters, Rolf
Weckesser, Matthias
Kroschinsky, Frank
Kotzerke, Joerg
Ganser, Arnold
Bengel, Frank M.
La Rosee, Paul
Freesmeyer, Martin
Hoeffkes, Heinz-Gert
Hertel, Andreas
Behringer, Dirk
Prange-Krex, Gabriele
Griesshammer, Martin
Holzinger, Jens
Wilop, Stefan
Krohn, Thomas
Raghavachar, Aruna
Maschmeyer, Georg
Brink, Ingo
Schroers, Roland
Gaska, Tobias
Bernhard, Helga
Giagounidis, Aristoteles
Schuette, Jochen
Dienst, Ariane
Hautzel, Hubertus
Naumann, Ralph
Klein, Alfred
Hahn, Dennis
Poepperl, Gabriele
Grube, Matthias
Marienhagen, Joerg
Schwarzer, Andreas
Kurch, Lars
Hoehler, Thomas
Steiniger, Heike
Nueckel, Holger
Suedhoff, Thomas
Roemer, Wolfgang
Brinkmann, Marcus
Ose, Claudia
Alashkar, Ferras
Schmitz, Christine
Duerig, Jan
Hoelzer, Dieter
ANNALS OF HEMATOLOGY, 2019, 98 (04) : 897 - 907
[49] Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
Andreas Hüttmann
Jan Rekowski
Stefan P. Müller
Bernd Hertenstein
Christiane Franzius
Rolf Mesters
Matthias Weckesser
Frank Kroschinsky
Jörg Kotzerke
Arnold Ganser
Frank M. Bengel
Paul La Rosée
Martin Freesmeyer
Heinz-Gert Höffkes
Andreas Hertel
Dirk Behringer
Gabriele Prange-Krex
Martin Griesshammer
Jens Holzinger
Stefan Wilop
Thomas Krohn
Aruna Raghavachar
Georg Maschmeyer
Ingo Brink
Roland Schroers
Tobias Gaska
Helga Bernhard
Aristoteles Giagounidis
Jochen Schütte
Ariane Dienst
Hubertus Hautzel
Ralph Naumann
Alfred Klein
Dennis Hahn
Gabriele Pöpperl
Matthias Grube
Jörg Marienhagen
Andreas Schwarzer
Lars Kurch
Thomas Höhler
Heike Steiniger
Holger Nückel
Thomas Südhoff
Wolfgang Römer
Marcus Brinkmann
Claudia Ose
Ferras Alashkar
Christine Schmitz
Jan Dürig
Dieter Hoelzer
Annals of Hematology, 2019, 98 : 897 - 907
[50] No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study
Sehn, Laurie H.
Congiu, Angela Giovanna
Culligan, Dominic J.
Gironella, Mercedes
Yoon, Dok Hyun
Ogura, Michinori
Rosta, Andras
Zhu, Jun
Launonen, Aino
Nielsen, Tina
Sellam, Gila
Trneny, Marek
Vitolo, Umberto
Martelli, Maurizio
BLOOD, 2018, 132

← 1 2 3 4 5 →